한글목차

세계 골시멘트 및 뼈 접착제 시장 규모는 2023년 16억 4,400만 달러에서 2028년에는 22억 4,800만 달러에 달할 것으로 예상되며, 예측 기간 동안 6.5%의 CAGR을 나타낼 것으로 예상됩니다.

골절과 수술 증가, 전략적 제휴 및 파트너십이 이 시장의 성장을 이끄는 주요 원동력입니다. 그러나 비용과 경제성 문제는 이 시장의 성장을 위협할 수 있는 요인으로 작용할 수 있습니다.

전치환술 무릎관절 전치환술은 예측 기간 동안 가장 높은 CAGR로 성장할 것으로 예상됩니다. 무릎 골관절염의 유병률 증가와 고령화로 인해 세계적으로 TKA 수술 건수가 증가하고 있으며, 이는 뼈 접착제 및 시멘트 시장을 주도하고 있습니다.

유럽 시장은 예측 기간 동안 세 번째로 높은 성장률을 기록할 것으로 예상됩니다. 이 시장 성장의 주요 원동력은 65세 이상 인구의 비율이 높고 고령화가 빠르게 진행되고 있기 때문입니다. 고령화 사회에서는 골관절염, 골절과 같은 정형외과 질환이 발생하기 쉬우며, 골 시멘트나 접착제를 이용한 수술이 필요한 경우가 많습니다.

본 보고서는 세계의 골시멘트 및 뼈 접착제 시장을 조사했으며, 시장 개요와 함께 골시멘트별/뼈 접착제별/하중별/용도별/최종사용자별/지역별 동향, 시장 출기업 프로파일 등의 정보를 전해드립니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 프리미엄 인사이트

제5장 시장 개요

• 서론
• 시장 역학

제6장 골시멘트 및 뼈 접착제 시장, 유형별

• 서론
• 골시멘트
• 뼈 접착제

제7장 골시멘트 및 뼈 접착제 시장, 용도별

• 서론
• 관절 성형술
• 척주 후만 성형술
• 추골 성형술
• 기타

제8장 골시멘트 및 뼈 접착제 시장, 최종사용자별

• 서론
• 병원/ASCS
• 클리닉/의원

제9장 골시멘트 및 뼈 접착제 시장, 지역별

• 서론
• 북미
• 유럽
• 아시아태평양
• 기타 지역

제10장 경쟁 구도

• 개요
• 주요 참여 기업의 전략/유력 기업
• 시장 점유율 분석, 2022년
• 매출 점유율 분석, 2022년
• 기업 평가 매트릭스, 2022년
• 중소기업/신규 기업용 기업 평가 매트릭스, 2022년
• 경쟁 벤치마킹
• 기업 실적 분석
• 경쟁 시나리오

제11장 기업 개요

• 주요 참여 기업
  • STRYKER
  • ZIMMER BIOMET
  • HERAEUS HOLDING
  • SMITH+NEPHEW
  • DEPUY SYNTHES(JOHNSON & JOHNSON)
  • ENOVIS
  • ARTIVION, INC.
  • CARDINAL HEALTH
  • MEDTRONIC
  • GLOBUS MEDICAL
  • EXACTECH, INC.
  • ARTHREX, INC.
  • TEKNIMED
  • TECRES S.P.A.
  • BIOCERAMED S.A.
  • EVOLUTIS
• 기타 기업
  • NORMMED MEDICAL
  • LINACOL MEDICAL INC.
  • BPB MEDICA
  • IZI MEDICAL
  • ADITUS MEDICAL
  • OSARTIS GMBH
  • LD DAVIS
  • MILLIGAN & HIGGINS
  • VHERN S.R.L.

제12장 부록

영문목차

The global Bone Cement & Glue Market is projected to reach USD 2,248 million by 2028 from USD 1,644 million in 2023, at a CAGR of 6.5% during the forecast period. The growth of this market is majorly driven by Increasing number of bone fractures and surgeries and Strategic Collaborations and Partnerships. However, Challenges associated with cost and affordability may threat the growth of this market.

"Total knee arthroplasty in the type of segment to witness the highest growth during the forecast period."

Based on the Type, the arthroplasty market is segmented into Total knee arthroplasty, Total hip arthroplasty

Total shoulder arthroplasty. Total knee arthroplasty is projected to grow at the highest CAGR during the forecast period. The significant factors contributing to the growth of this market is The increasing prevalence of knee osteoarthritis and the aging population have contributed to a growing number of TKA procedures worldwide which drives the bone glue and cement market.

"Europe is estimated to register the third highest CAGR during the forecast period."

In this report, the Bone cement & glue market is segmented into four major regional segments: North America, Europe, Asia Pacific, Rest of the world. The market in Europe is projected to register the third highest growth rate during the forecast period. The growth in this market is primarily driven by the presence of significant aging population, with a higher proportion of individuals aged 65 and above. The aging demographic is more prone to orthopedic conditions, such as osteoarthritis and fractures, which often require surgical interventions using bone cement and glue, High Prevalence of Orthopedic Conditions, Growing Number of Orthopedic Surgeries, and Technological Advancements in healthcare sectors.

Breakdown of supply-side primary interviews, by company type, designation, and region:

• By Company Type: Tier 1 (48%), Tier 2 (34%), and Tier 3 (18%)
• By Designation: C-level (33%), Director-level (40%), and Others (27%)
• By Region: North America (36%), Europe (28%), AsiaPacific (20%), Rest of the World (16%)

List of Companies Profiled in the Report

• Stryker (US)
• Zimmer Biomet (US)
• DePuy Synthes (a subsidiary of Johnson & Johnson - US)
• Smith+Nephew.(UK)
• Arthrex, Inc. (US)
• Enovis (US)
• Globus Medical (US)
• Exactech, Inc.(US)
• Heraeus Holding (Germany)
• Artivion, Inc (US)
• Cardinal Health. (US)
• Teknimed (France)
• Medtronic (Ireland)
• Tecres S.p.A.(Italy)
• Bioceramed, S.A. (Portugal)
• Evolutis (France)
• Normmed Medical (Turkey)
• LINACOL Medical (Turkey)
• BPB MEDICA (Italy)
• IZI Medical (US)
• Aditus Medical. (Germany)
• OSARTIS GmbH (Germany)
• LD Davis (US)
• Milligan & Higgins (US)
• VHERN srl (US)

Research Coverage:

This report studies the Bone cement & glue market based on product and region. The report also analyzes factors (such as drivers, opportunities, and challenges, restraints) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total Bone cement & glue market. The report forecasts the revenue of the market segments with respect to five major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on bio decontamination products offered by the top 25 players in the Bone cement & glue market. The report analyzes the Bone cement & glue market by Type, and region.
• Market Drivers: Comprehensive information about the factors and conditions that stimulate and influence the growth and performance of a specific market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.
• Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the Bone cement & glue market.
• Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the Bone cement & glue market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS AND EXCLUSIONS
• 1.3 MARKET SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 REGIONS COVERED
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 LIMITATIONS
• 1.5 STAKEHOLDERS
• 1.6 RECESSION IMPACT

2 RESEARCH METHODOLOGY

• FIGURE 1 RESEARCH DESIGN
• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
  • FIGURE 2 PRIMARY SOURCES
    • 2.1.2.1 Breakdown of primary interviews
    • 2.1.2.2 Key data from primary sources
• 2.2 MARKET SIZE ESTIMATION
  • FIGURE 3 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 4 BOTTOM-UP APPROACH: PROCEDURE-BASED ANALYSIS
  • 2.2.1 GROWTH FORECAST
  • FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 6 TOP-DOWN APPROACH
• 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • FIGURE 7 DATA TRIANGULATION METHODOLOGY
• 2.4 ASSUMPTIONS
• 2.5 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

• FIGURE 8 BONE CEMENT & GLUE MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
• FIGURE 9 BONE CEMENT & GLUE MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
• FIGURE 10 BONE CEMENT & GLUE MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
• FIGURE 11 BONE CEMENT & GLUE MARKET, BY REGION, 2023 VS. 2028 (USD MILLION)

4 PREMIUM INSIGHTS

• 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN BONE CEMENT & GLUE MARKET
  • FIGURE 12 GROWING GERIATRIC POPULATION TO DRIVE MARKET
• 4.2 BONE CEMENT MARKET, BY TYPE
  • FIGURE 13 PMMA CEMENT TO REGISTER HIGHER GROWTH OVER FORECAST PERIOD
• 4.3 NORTH AMERICA: BONE CEMENT & GLUE MARKET, BY TYPE AND COUNTRY
  • FIGURE 14 US ACCOUNTED FOR LARGEST MARKET SHARE IN NORTH AMERICA IN 2022
• 4.4 BONE CEMENT & GLUE MARKET, BY COUNTRY
  • FIGURE 15 INDIA AND CHINA TO REGISTER HIGHEST GROWTH OVER FORECAST PERIOD

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • FIGURE 16 BONE CEMENT & GLUE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 5.2.1 DRIVERS
    • 5.2.1.1 Growing incidence of sports injuries
    • 5.2.1.2 Rapid growth in geriatric population
  • TABLE 1 GERIATRIC POPULATION, BY REGION, 2015 VS. 2030 VS. 2050 (MILLION)
    • 5.2.1.3 Developments in regenerative medicine
    • 5.2.1.4 Growing number of road traffic accidents and other factors increasing surgery volumes
    • 5.2.1.5 Technological advancements
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High costs and extensive clinical data requirements for launching new products
    • 5.2.2.2 Alternatives to bone cement and glue
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Growth opportunities in emerging economies
    • 5.2.3.2 Rising awareness and demand for minimally invasive procedures
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Development of novel biomaterials with high mechanical properties and adhesion strength
    • 5.2.4.2 Product-related complications
    • 5.2.4.3 Unfavorable reimbursement scenario

6 BONE CEMENT & GLUE MARKET, BY TYPE

• 6.1 INTRODUCTION
  • TABLE 2 BONE CEMENT & GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
• 6.2 BONE CEMENT
  • TABLE 3 CONSTITUENTS OF BONE CEMENT
  • TABLE 4 BONE CEMENT MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.2.1 BONE CEMENT MARKET, BY TYPE
  • TABLE 5 BONE CEMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • 6.2.1.1 PMMA cement
      • 6.2.1.1.1 Wide usage and properties of PMMA to drive market
  • TABLE 6 PMMA CEMENT MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.1.2 Calcium phosphate cement
      • 6.2.1.2.1 High biocompatibility and radiopacity to drive adoption
  • TABLE 7 CPC MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.1.3 Glass polyalkenoate cement
      • 6.2.1.3.1 Wide applications in dentistry to drive market
  • TABLE 8 GPC MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.2.2 BONE CEMENT MARKET, BY LOADING
  • TABLE 9 BONE CEMENT MARKET, BY LOADING, 2021-2028 (USD MILLION)
    • 6.2.2.1 Antibiotic-loaded bone cement
      • 6.2.2.1.1 High risk of developing deep infections during surgeries to support adoption
  • TABLE 10 ANTIBIOTIC-LOADED BONE CEMENT MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.2.2 Non-antibiotic-loaded bone cement
      • 6.2.2.2.1 Low cost and less-stringent regulations to support usage
  • TABLE 11 NON-ANTIBIOTIC-LOADED BONE CEMENT MARKET, BY REGION, 2021-2028 (USD MILLION)
• 6.3 BONE GLUE
  • TABLE 12 BONE GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 13 BONE GLUE MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3.1 NATURAL BONE GLUE
    • 6.3.1.1 High biocompatibility to support greater adoption
  • TABLE 14 NATURAL BONE GLUE MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3.2 SYNTHETIC BONE GLUE
    • 6.3.2.1 Emerging medical applications indicate high potential of synthetic glue
  • TABLE 15 SYNTHETIC BONE GLUE MARKET, BY REGION, 2021-2028 (USD MILLION)

7 BONE CEMENT & GLUE MARKET, BY APPLICATION

• 7.1 INTRODUCTION
  • TABLE 16 BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
• 7.2 ARTHROPLASTY
  • TABLE 17 BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 18 BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021-2028 (USD MILLION)
  • 7.2.1 TOTAL KNEE ARTHROPLASTY
    • 7.2.1.1 TKA to hold largest arthroplasty market share
  • TABLE 19 BONE CEMENT & GLUE MARKET FOR TOTAL KNEE ARTHROPLASTY, BY REGION, 2021-2028 (USD MILLION)
  • 7.2.2 TOTAL HIP ARTHROPLASTY
    • 7.2.2.1 Growing geriatric population to boost procedural volumes
  • TABLE 20 BONE CEMENT & GLUE MARKET FOR TOTAL HIP ARTHROPLASTY, BY REGION, 2021-2028 (USD MILLION)
  • 7.2.3 TOTAL SHOULDER ARTHROPLASTY
    • 7.2.3.1 Rising sports injury incidence to drive market
  • TABLE 21 BONE CEMENT & GLUE MARKET FOR TOTAL SHOULDER ARTHROPLASTY, BY REGION, 2021-2028 (USD MILLION)
• 7.3 KYPHOPLASTY
  • 7.3.1 INCREASING INCIDENCE OF OSTEOPOROSIS TO DRIVE MARKET
  • TABLE 22 TOP TEN COUNTRIES IN KYPHOPLASTY RESEARCH
  • TABLE 23 BONE CEMENT & GLUE MARKET FOR KYPHOPLASTY, BY REGION, 2021-2028 (USD MILLION)
• 7.4 VERTEBROPLASTY
  • 7.4.1 RISING INCIDENCE OF VERTEBRAL COMPRESSION FRACTURES TO SUPPORT MARKET GROWTH
  • TABLE 24 BONE CEMENT & GLUE MARKET FOR VERTEBROPLASTY, BY REGION, 2021-2028 (USD MILLION)
• 7.5 OTHER APPLICATIONS
  • TABLE 25 BONE CEMENT & GLUE MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)

8 BONE CEMENT & GLUE MARKET, BY END USER

• 8.1 INTRODUCTION
  • TABLE 26 BONE CEMENT & GLUE MARKET, BY END USER, 2021-2028 (USD MILLION)
• 8.2 HOSPITALS & ASCS
  • 8.2.1 HOSPITALS & ASCS TO DOMINATE END-USER MARKET
  • TABLE 27 BONE CEMENT & GLUE MARKET FOR HOSPITALS & ASCS, BY REGION, 2021-2028 (USD MILLION)
• 8.3 CLINICS & PHYSICIAN OFFICES
  • 8.3.1 RISING PREFERENCE FOR CLINICS AND COST-SAVING POTENTIAL TO DRIVE MARKET
  • TABLE 28 BONE CEMENT & GLUE MARKET FOR CLINICS & PHYSICIAN OFFICES, BY REGION, 2021-2028 (USD MILLION)

9 BONE CEMENT & GLUE MARKET, BY REGION

• 9.1 INTRODUCTION
  • TABLE 29 BONE CEMENT & GLUE MARKET, BY REGION, 2021-2028 (USD MILLION)
• 9.2 NORTH AMERICA
  • 9.2.1 NORTH AMERICA: RECESSION IMPACT
  • FIGURE 17 NORTH AMERICA: BONE CEMENT & GLUE MARKET SNAPSHOT
  • TABLE 30 NORTH AMERICA: BONE CEMENT & GLUE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 31 NORTH AMERICA: BONE CEMENT & GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 32 NORTH AMERICA: BONE CEMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 33 NORTH AMERICA: BONE CEMENT MARKET, BY LOADING, 2021-2028 (USD MILLION)
  • TABLE 34 NORTH AMERICA: BONE GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 35 NORTH AMERICA: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 36 NORTH AMERICA: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 37 NORTH AMERICA: BONE CEMENT & GLUE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.2.2 US
    • 9.2.2.1 Growing geriatric population and high prevalence of sports injuries to drive market
  • FIGURE 18 TOTAL ESTIMATED INJURIES BY SPORTS ACTIVITY IN 2021
  • TABLE 38 US: KEY MACROINDICATORS
  • TABLE 39 US: BONE CEMENT & GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 40 US: BONE CEMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 41 US: BONE CEMENT MARKET, BY LOADING, 2021-2028 (USD MILLION)
  • TABLE 42 US: BONE GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 43 US: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 44 US: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 45 US: BONE CEMENT & GLUE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.2.3 CANADA
    • 9.2.3.1 Availability of government funding and growth in geriatric population to drive market
  • TABLE 46 FUNDS FOR SPORTS ORGANIZATIONS, 2021/2022 (USD THOUSAND)
  • TABLE 47 CANADA: KEY MACROINDICATORS
  • TABLE 48 CANADA: BONE CEMENT & GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 49 CANADA: BONE CEMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 50 CANADA: BONE CEMENT MARKET, BY LOADING, 2021-2028 (USD MILLION)
  • TABLE 51 CANADA: BONE GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 52 CANADA: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 53 CANADA: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 54 CANADA: BONE CEMENT & GLUE MARKET, BY END USER, 2021-2028 (USD MILLION)
• 9.3 EUROPE
  • TABLE 55 EUROPE: BURDEN OF OSTEOPOROSIS (2021)
  • 9.3.1 EUROPE: RECESSION IMPACT
  • TABLE 56 EUROPE: BONE CEMENT & GLUE MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 57 EUROPE: BONE CEMENT & GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 58 EUROPE: BONE CEMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 59 EUROPE: BONE CEMENT MARKET, BY LOADING, 2021-2028 (USD MILLION)
  • TABLE 60 EUROPE: BONE GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 61 EUROPE: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 62 EUROPE: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 63 EUROPE: BONE CEMENT & GLUE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.3.2 FRANCE
    • 9.3.2.1 Rising government support to drive demand
  • TABLE 64 FRANCE: KEY MACROINDICATORS
  • TABLE 65 FRANCE: BONE CEMENT & GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 66 FRANCE: BONE CEMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 67 FRANCE: BONE CEMENT MARKET, BY LOADING, 2021-2028 (USD MILLION)
  • TABLE 68 FRANCE: BONE GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 69 FRANCE: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 70 FRANCE: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 71 FRANCE: BONE CEMENT & GLUE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.3.3 GERMANY
    • 9.3.3.1 Robust healthcare spending and advanced healthcare system to favor market growth
  • TABLE 72 GERMANY: KEY MACROINDICATORS
  • TABLE 73 GERMANY: BONE CEMENT & GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 74 GERMANY: BONE CEMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 75 GERMANY: BONE CEMENT MARKET, BY LOADING, 2021-2028 (USD MILLION)
  • TABLE 76 GERMANY: BONE GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 77 GERMANY: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 78 GERMANY: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 79 GERMANY: BONE CEMENT & GLUE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.3.4 UK
    • 9.3.4.1 Presence of strong healthcare infrastructure and high burden of orthopedic cases
  • TABLE 80 UK: KEY MACROINDICATORS
  • TABLE 81 UK: BONE CEMENT & GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 82 UK: BONE CEMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 83 UK: BONE CEMENT MARKET, BY LOADING, 2021-2028 (USD MILLION)
  • TABLE 84 UK: BONE GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 85 UK: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 86 UK: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 87 UK: BONE CEMENT & GLUE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.3.5 REST OF EUROPE
  • TABLE 88 REST OF EUROPE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2021 (% OF GDP)
  • TABLE 89 REST OF EUROPE: BONE CEMENT & GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 90 REST OF EUROPE: BONE CEMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 91 REST OF EUROPE: BONE CEMENT MARKET, BY LOADING, 2021-2028 (USD MILLION)
  • TABLE 92 REST OF EUROPE: BONE GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 93 REST OF EUROPE: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 94 REST OF EUROPE: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 95 REST OF EUROPE: BONE CEMENT & GLUE MARKET, BY END USER, 2021-2028 (USD MILLION)
• 9.4 ASIA PACIFIC
  • 9.4.1 ASIA PACIFIC: RECESSION IMPACT
  • FIGURE 19 ASIA PACIFIC: BONE CEMENT & GLUE MARKET SNAPSHOT
  • TABLE 96 ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY COUNTRY/REGION, 2021-2028 (USD MILLION)
  • TABLE 97 ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 98 ASIA PACIFIC: BONE CEMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 99 ASIA PACIFIC: BONE CEMENT MARKET, BY LOADING, 2021-2028 (USD MILLION)
  • TABLE 100 ASIA PACIFIC: BONE GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 101 ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 102 ASIA PACIFIC: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 103 ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.4.2 CHINA
    • 9.4.2.1 China to hold largest market share in APAC
  • TABLE 104 CHINA: KEY MACROINDICATORS
  • TABLE 105 INCIDENCE OF OSTEOPOROTIC FRACTURES IN CHINA, 2015-2035
  • TABLE 106 CHINA: BONE CEMENT & GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 107 CHINA: BONE CEMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 108 CHINA: BONE CEMENT MARKET, BY LOADING, 2021-2028 (USD MILLION)
  • TABLE 109 CHINA: BONE GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 110 CHINA: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 111 CHINA: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 112 CHINA: BONE CEMENT & GLUE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.4.3 INDIA
    • 9.4.3.1 Rising medical tourism, improving healthcare infrastructure, and growing population to drive market
  • TABLE 113 INDIA: KEY MACROINDICATORS
  • TABLE 114 INDIA: BONE CEMENT & GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 115 INDIA: BONE CEMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 116 INDIA: BONE CEMENT MARKET, BY LOADING, 2021-2028 (USD MILLION)
  • TABLE 117 INDIA: BONE GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 118 INDIA: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 119 INDIA: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 120 INDIA: BONE CEMENT & GLUE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.4.4 JAPAN
    • 9.4.4.1 Large aging population and favorable government initiatives to drive market
  • TABLE 121 JAPAN: KEY MACROINDICATORS
  • TABLE 122 JAPAN: BONE CEMENT & GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 123 JAPAN: BONE CEMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 124 JAPAN: BONE CEMENT MARKET, BY LOADING, 2021-2028 (USD MILLION)
  • TABLE 125 JAPAN: BONE GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 126 JAPAN: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 127 JAPAN: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 128 JAPAN: BONE CEMENT & GLUE MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.4.5 REST OF ASIA PACIFIC
  • TABLE 129 REST OF ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 130 REST OF ASIA PACIFIC: BONE CEMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 131 REST OF ASIA PACIFIC: BONE CEMENT MARKET, BY LOADING, 2021-2028 (USD MILLION)
  • TABLE 132 REST OF ASIA PACIFIC: BONE GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 133 REST OF ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 134 REST OF ASIA PACIFIC: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 135 REST OF ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY END USER, 2021-2028 (USD MILLION)
• 9.5 REST OF THE WORLD
  • TABLE 136 US VS. MEXICO: AVERAGE COST COMPARISON (USD)
  • 9.5.1 ROW: RECESSION IMPACT
  • TABLE 137 REST OF THE WORLD: BONE CEMENT & GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 138 REST OF THE WORLD: BONE CEMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 139 REST OF THE WORLD: BONE CEMENT MARKET, BY LOADING, 2021-2028 (USD MILLION)
  • TABLE 140 REST OF THE WORLD: BONE GLUE MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 141 REST OF THE WORLD: BONE CEMENT & GLUE MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 142 REST OF THE WORLD: BONE CEMENT & GLUE MARKET FOR ARTHROPLASTY, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 143 REST OF THE WORLD: BONE CEMENT & GLUE MARKET, BY END USER, 2021-2028 (USD MILLION)

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • TABLE 144 OVERVIEW OF STRATEGIES ADOPTED BY KEY BONE CEMENT & GLUE MARKET PLAYERS
• 10.3 MARKET SHARE ANALYSIS, 2022
  • FIGURE 20 BONE CEMENT & GLUE MARKET SHARE ANALYSIS, 2022
  • TABLE 145 BONE CEMENT & GLUE MARKET: DEGREE OF COMPETITION (2022)
• 10.4 REVENUE SHARE ANALYSIS, 2022
  • FIGURE 21 REVENUE ANALYSIS OF TOP FOUR MARKET PLAYERS (USD MILLION)
• 10.5 COMPANY EVALUATION MATRIX, 2022
  • 10.5.1 STARS
  • 10.5.2 EMERGING LEADERS
  • 10.5.3 PERVASIVE PLAYERS
  • 10.5.4 PARTICIPANTS
  • FIGURE 22 BONE CEMENT & GLUE MARKET: COMPANY EVALUATION MATRIX (2022)
• 10.6 COMPANY EVALUATION MATRIX FOR SMES/STARTUPS, 2022
  • 10.6.1 PROGRESSIVE COMPANIES
  • 10.6.2 STARTING BLOCKS
  • 10.6.3 RESPONSIVE COMPANIES
  • 10.6.4 DYNAMIC COMPANIES
  • FIGURE 23 BONE CEMENT & GLUE MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)
• 10.7 COMPETITIVE BENCHMARKING
  • TABLE 146 BONE CEMENT & GLUE MARKET: DETAILED LIST OF KEY SMES/STARTUPS
• 10.8 COMPANY FOOTPRINT ANALYSIS
  • TABLE 147 COMPANY FOOTPRINT ANALYSIS
  • TABLE 148 COMPANY PRODUCT FOOTPRINT
  • TABLE 149 COMPANY REGIONAL FOOTPRINT
• 10.9 COMPETITIVE SCENARIO
  • 10.9.1 DEALS
  • TABLE 150 DEALS
  • 10.9.2 OTHER DEVELOPMENTS
  • TABLE 151 OTHER DEVELOPMENTS

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
• (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
• 11.1.1 STRYKER
• TABLE 152 STRYKER: BUSINESS OVERVIEW
• FIGURE 24 STRYKER: COMPANY SNAPSHOT (2022)
• 11.1.2 ZIMMER BIOMET
• TABLE 153 ZIMMER BIOMET: BUSINESS OVERVIEW
• FIGURE 25 ZIMMER BIOMET: COMPANY SNAPSHOT (2022)
• 11.1.3 HERAEUS HOLDING
• TABLE 154 HERAEUS HOLDING: BUSINESS OVERVIEW
• 11.1.4 SMITH+NEPHEW
• TABLE 155 SMITH+NEPHEW: BUSINESS OVERVIEW
• FIGURE 26 SMITH & NEPHEW: COMPANY SNAPSHOT (2022)
• 11.1.5 DEPUY SYNTHES (JOHNSON & JOHNSON)
• TABLE 156 JOHNSON & JOHNSON: BUSINESS OVERVIEW
• FIGURE 27 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2022)
• 11.1.6 ENOVIS
• TABLE 157 ENOVIS: BUSINESS OVERVIEW
• FIGURE 28 ENOVIS: COMPANY SNAPSHOT (2022)
• 11.1.7 ARTIVION, INC.
• TABLE 158 ARTIVION, INC.: BUSINESS OVERVIEW
• FIGURE 29 ARTIVION, INC.: COMPANY SNAPSHOT (2022)
• 11.1.8 CARDINAL HEALTH
• TABLE 159 CARDINAL HEALTH: BUSINESS OVERVIEW
• FIGURE 30 CARDINAL HEALTH.: COMPANY SNAPSHOT (2022)
• 11.1.9 MEDTRONIC
• TABLE 160 MEDTRONIC: BUSINESS OVERVIEW
• FIGURE 31 MEDTRONIC: COMPANY SNAPSHOT (2022)
• 11.1.10 GLOBUS MEDICAL
• TABLE 161 GLOBUS MEDICAL: BUSINESS OVERVIEW
• FIGURE 32 GLOBUS MEDICAL: COMPANY SNAPSHOT (2022)
• 11.1.11 EXACTECH, INC.
• TABLE 162 EXACTECH, INC.: BUSINESS OVERVIEW
• 11.1.12 ARTHREX, INC.
• TABLE 163 ARTHREX, INC.: BUSINESS OVERVIEW
• 11.1.13 TEKNIMED
• TABLE 164 TEKNIMED: BUSINESS OVERVIEW
• 11.1.14 TECRES S.P.A.
• TABLE 165 TECRES S.P.A.: BUSINESS OVERVIEW
• 11.1.15 BIOCERAMED S.A.
• TABLE 166 BIOCERAMED, S.A.: BUSINESS OVERVIEW
• 11.1.16 EVOLUTIS
• TABLE 167 EVOLUTIS: BUSINESS OVERVIEW
• 11.2 OTHER PLAYERS
  • 11.2.1 NORMMED MEDICAL
  • 11.2.2 LINACOL MEDICAL INC.
  • 11.2.3 BPB MEDICA
  • 11.2.4 IZI MEDICAL
  • 11.2.5 ADITUS MEDICAL
  • 11.2.6 OSARTIS GMBH
  • 11.2.7 LD DAVIS
  • 11.2.8 MILLIGAN & HIGGINS
  • 11.2.9 VHERN S.R.L.
• *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12 APPENDIX

• 12.1 INDUSTRY INSIGHTS
• 12.2 DISCUSSION GUIDE
• 12.3 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.4 CUSTOMIZATION OPTIONS
• 12.5 RELATED REPORTS
• 12.6 AUTHOR DETAILS